Ledger.Open graph →
SEC Form D · filed December 6, 2023

Gila Therapeutics, Inc

Offering
$10.0M
Sold
$400K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Edina, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Timothy Barberich · Boston, MADirectorPraveen Tyle · Waltham, MADirectorThomas Vasicek · Boston, MAExecChristopher De Souza · Boston, MADirectorJon Freeman · Minneapolis, MNExecRichard Horan · Providence, RIDirectorScott Schorer · Boston, MAExec · DirectorSangeeta Kashyap · Edina, MNExecTimothy Barberich · Framingham, MADirectorChristopher De Souza · Boston, MADirectorPraveen Tyle · Waltham, MADirectorJon Freeman · Maple Grove, MNExecThomas Vasicek · Boston, MAExecRichard Horan · Providence, RIDirectorScott Schorer · Boston, MAExec · DirectorSangeeta Kashyap · Edina, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗